Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

Vaccine candidate

Search

Categories

Recent Posts

Post Image

As Efforts Intensify to Contain Bundibugyo Ebola, Women Remain Most Vulnerable to Its Economic Impact

Jul 06, 2026
Post Image

An Epidemic of Parastatals in Nigeria’s Health Sector

Jul 04, 2026
Post Image

From Innovation to Integration: What It Will Take to Make Every Pregnancy Safer in Nigeria

Jul 03, 2026
Post Image

Community Feedback Prompts PHC Upgrade in Gauraka, Niger State

Jul 03, 2026
Post Image

Why Zambia is Rethinking Tuberculosis Testing, and Why Validation Must Come First

Jul 02, 2026
Blog Image
By Nigeria Health Watch | June 15, 2021

EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development

Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK, THE HAGUE, AND OSLO – JUNE 15, 2021 – IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct […]

Read More